MA-ONPROCESS-TECHNOLOGY
12.1.2022 13:47:13 CET | Business Wire | Press release
OnProcess Technology, a global pioneer powering the world’s circular service value chains, has been featured in Everest Group’s Supply Chain Management (SCM) BPS – Service Provider Landscape with PEAK Matrix® Assessment 2022.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220112005570/en/
Everest Group evaluated 14 leading Supply Chain Management service providers and has positioned OnProcess as a Major Contender . In addition to this, based on OnProcess’s vision, capabilities and market impact, the company was recognized as one of just four Star Performers in the report.
According to Everest Group, OnProcess is one of the few providers that leverages an experience-oriented approach towards its SCM offerings focusing on user interface / user experience (UX) of its solutions. The report also highlights OnProcess’s expertise serving large clients in fast-growing industries such as hi-tech & telecom, healthcare & life sciences.
Everest Group also noted that OnProcess achieved one of the highest buyer satisfaction ratings among all service providers, and was one of few providers that continued to invest in improving user experience and user interface of its solutions.
The report also recognizes OnProcess’s new proprietary cloud-based platform, OnProcess Agora™, as a key strength of the company, and the means by which it can offer its services (across planning, delivery and recovery) in highly agile/flexible models such as SaaS / BPaaS and platform-enabled digital services.
“OnProcess Technology, a specialist service provider with a strong focus on after-sales services and service parts management, strengthens its Major Contender position in Everest Group’s Supply Chain Management (SCM) BPS – PEAK Matrix® Assessment 2022 by enabling more agility/flexibility in its service model through the launch of a new proprietary cloud-based platform, OnProcess Agora™,” said Shirley Hung, Partner, Everest Group. “Its experience-oriented approach, one of the highest buyer satisfaction ratings among all assessed service providers, and significant increase in penetration in industries such as hi-tech and healthcare, helped it earn a Star Performer designation in this year’s assessment.”
“We are honored Everest Group has named us a Star Performer and Major Contender in their latest PEAK Matrix report. Their assessment also provides incredible validation for our new cloud-based technology platform OnProcess Agora™, which is a key enabler of our company’s vision to power the world’s circular service supply chains, putting sustainability and customer lifetime value at the heart of what we do in the as-a-service economy,” said Oliver Lemanski, CEO of OnProcess. “But what makes us even prouder is that according to Everest Group, our clients highlight our proactive approach toward improving performance and partnership orientation as one of our key strengths, and that we achieved one of the highest buyer satisfaction ratings of all service providers.”
About OnProcess Technology, Inc.
OnProcess supplies technology and services that power the world’s circular service supply chains. Providing managed services and digital transformation expertise that streamlines processes, maximizes customer lifetime value, and improves ‘circular’ sustainability goals, OnProcess is a trusted advisor to many of the world’s leading computer, networking, med-tech, wireless, telecommunications, and IT companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220112005570/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom